Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PROUD: Early vs Delayed Pramipexole in Parkinson's Disease
NCT00321854Phase 4Completed
- Sponsor
- Boehringer Ingelheim
- Start
- May 2006
- Primary completion
- Apr 2009
- Modality
- Small Molecules
- Countries
- 10
01
Overview
Phase 4, randomised, double-blind trial of pramipexole in Parkinson's disease (PD) (2 arms), sponsored by Boehringer Ingelheim. Primary endpoint: Unified Parkinson's Disease Rating Scale Total Score at 15 months. Started May 2006; status: completed.
02
Drugs
pramipexole
03
Conditions
Parkinson's disease (PD)
Beyond the preview
Go deeper on NCT00321854.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00321854.